VST
TEVA icon

Van Strum & Towne’s Teva Pharmaceuticals TEVA Stock Holding History

Van Strum & Towne’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-90,006
Closed -$1.58M – 76
2017
Q3 		$1.58M Buy
90,006
+1,825
+2% +$41.1K 1.03% 29
2017
Q2 		$2.93M Hold
88,181
– – 1.91% 24
2017
Q1 		$2.83M Sell
88,181
-1,699
-2% -$58K 1.83% 26
2016
Q4 		$3.26M Sell
89,880
-868
-1% -$34.7K 2.04% 23
2016
Q3 		$4.17M Buy
90,748
+1,940
+2% +$101K 2.75% 13
2016
Q2 		$4.46M Sell
88,808
-1,073
-1% -$57.1K 2.96% 12
2016
Q1 		$4.81M Buy
89,881
+775
+0.9% +$45.5K 3.19% 12
2015
Q4 		$5.85M Buy
89,106
+5,395
+6% +$333K 3.79% 5
2015
Q3 		$4.73M Sell
83,711
-540
-0.6% -$35K 3.23% 8
2015
Q2 		$4.98M Hold
84,251
– – 3.06% 12
2015
Q1 		$5.25M Buy
84,251
+650
+0.8% +$37.8K 3.27% 9
2014
Q4 		$4.81M Buy
83,601
+850
+1% +$47.4K 2.97% 12
2014
Q3 		$4.45M Buy
82,751
+735
+0.9% +$38.9K 2.9% 13
2014
Q2 		$4.3M Sell
82,016
-4,080
-5% -$209K 2.81% 14
2014
Q1 		$4.55M Hold
86,096
– – 2.93% 14
2013
Q4 		$3.45M Buy
86,096
+4,200
+5% +$165K 2.3% 20
2013
Q3 		$3.09M Buy
81,896
+275
+0.3% +$10.7K 2.31% 22
2013
Q2 		$3.2M Buy
+81,621
New +$3.18M 2.46% 20

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Van Strum & Towne's TEVA Position: Q4 2017 in Review

Van Strum & Towne sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 90,006 shares — an estimated $1.58M sold.

Van Strum & Towne first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $5.85M in Q4 2015. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Van Strum & Towne reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Van Strum & Towne sold 90,006 Teva Pharmaceuticals shares in Q4 2017, an estimated $1.58M.
  • Van Strum & Towne first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Van Strum & Towne's Teva Pharmaceuticals position peaked at $5.85M in Q4 2015.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Van Strum & Towne's 13F filing for Q4 2017, filed 13 Feb 2018.